The global CNS Therapeutics Market is growing substantially due to innovation in treating neurological and psychiatric disorders, increasing from USD 123.7 billion in 2025 to an expected USD 184.5 billion by 2033, with a CAGR of 5.3%.
Read More:
https://m2squareconsultancy.co....m/reports/c-reactive
The Term CNS Therapeutics Market refers to medicines and treatments that target the central nervous system (CNS), which includes the brain and spinal cord. These therapeutics are designed to treat a wide range of neurological and psychiatric disorders by affecting how the CNS functions.